CN115710514A - Liquid crystal composition and liquid crystal display panel - Google Patents

Liquid crystal composition and liquid crystal display panel Download PDF

Info

Publication number
CN115710514A
CN115710514A CN202211400148.5A CN202211400148A CN115710514A CN 115710514 A CN115710514 A CN 115710514A CN 202211400148 A CN202211400148 A CN 202211400148A CN 115710514 A CN115710514 A CN 115710514A
Authority
CN
China
Prior art keywords
mentioned
liquid crystal
crystal composition
independently
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211400148.5A
Other languages
Chinese (zh)
Inventor
刘晓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TCL Huaxing Photoelectric Technology Co Ltd
Original Assignee
TCL Huaxing Photoelectric Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TCL Huaxing Photoelectric Technology Co Ltd filed Critical TCL Huaxing Photoelectric Technology Co Ltd
Priority to CN202211400148.5A priority Critical patent/CN115710514A/en
Publication of CN115710514A publication Critical patent/CN115710514A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention provides a liquid crystal composition and a liquid crystal display panel, wherein the liquid crystal composition comprises one or more compounds represented by a formula I and one or more compounds represented by a formula II; the formula I is as follows:
Figure DDA0003934638280000011
the formula II is:
Figure DDA0003934638280000012
wherein m, n and o are independently of one another 0,1 or 2 and m + n + o.ltoreq.4; z 1 、Z 2 、Z 3 And Z 4 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O‑、‑OCF 2 ‑、‑CH 2 CH 2 ‑、‑CH 2 O‑、‑OCH 2 Or an alkyl or alkyl ether having 1 to 7 carbon atoms; r is 1 、R 2 、R 3 、R 4 Independently of one another, is alkyl or alkoxy having 1 to 5 carbon atoms, or alkenyl, alkenyloxy, alkynyl or alkynyloxy having 2 to 5 carbon atoms;
Figure DDA0003934638280000013
independently of one another are
Figure DDA0003934638280000014
Figure DDA0003934638280000015
Figure DDA0003934638280000016
And is
Figure DDA0003934638280000017
At least one of which is
Figure DDA0003934638280000018

Description

Liquid crystal composition and liquid crystal display panel
Technical Field
The application relates to the field of display, in particular to a liquid crystal composition and a liquid crystal display panel.
Background
With the development of Display technology, flat panel Display devices such as Liquid Crystal Display (LCD) devices have advantages of high image quality, power saving, thin body, and wide application range, and thus are widely used in various consumer electronic products such as mobile phones, televisions, personal digital assistants, digital cameras, notebook computers, and desktop computers, and become the mainstream of Display devices.
In order to meet the requirements of various consumer electronic products, liquid crystal materials used for display elements and display devices in IPS display mode, FFS display mode, VA display mode, and the like are required to have (1) low driving voltage: the liquid crystal material has larger dielectric anisotropy; (2) quick response: the liquid crystal material has lower viscosity and higher elastic coefficient; (3) high temperature resistance: the liquid crystal material has higher clearing point; (4) high contrast: the liquid crystal material has proper optical anisotropy and dielectric negativity.
In order to achieve better display effect, the contrast, response time, and other properties of the conventional liquid crystal display panel need to be further improved.
Disclosure of Invention
The invention provides a liquid crystal composition and a liquid crystal display panel, which are used for improving the performances of the liquid crystal display panel such as contrast, response time and the like.
In order to solve the above problems, the technical scheme provided by the invention is as follows:
the invention provides a liquid crystal composition, which comprises one or more compounds represented by a formula I and one or more compounds represented by a formula II;
the formula I is specifically as follows:
Figure BDA0003934638260000011
wherein m, n and o are independently of one another 0,1 or 2 and m + n + o.ltoreq.4;
each Z 1 Each Z 2 、Z 3 And each Z 4 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-, or an alkyl or alkyl ether having 1 to 7 carbon atoms, or an alkenyl, alkenyl ether, alkynyl or alkynyl ether having 2 to 7 carbon atoms; each Z 1 Each Z 2 、Z 3 And each Z 4 One or more of H in (a) may be substituted by F, cl, br, I;
R 1 and R 2 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 1 to 15 carbon atoms; said R is 1 The terminal group of (A), the R 2 May be H, CN or CF 3 Monosubstitution, said R 1 And said R 2 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I;
each one of which is
Figure BDA0003934638260000021
Each one of which is
Figure BDA0003934638260000022
And each one of
Figure BDA0003934638260000023
Each independently of the other is
Figure BDA0003934638260000024
Figure BDA0003934638260000025
Figure BDA0003934638260000026
And said
Figure BDA0003934638260000027
The above-mentioned
Figure BDA0003934638260000028
The above-mentioned
Figure BDA0003934638260000029
The above-mentioned
Figure BDA00039346382600000210
And said
Figure BDA00039346382600000211
At least one of which is
Figure BDA00039346382600000212
Each of said
Figure BDA00039346382600000213
Each of said
Figure BDA00039346382600000214
The above-mentioned
Figure BDA00039346382600000215
The described
Figure BDA00039346382600000216
And each of said
Figure BDA00039346382600000217
One or more of H in (a) may be substituted by F, cl, br;
the formula II is specifically as follows:
Figure BDA00039346382600000218
wherein R is 3 And R 4 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 3 The terminal group of (A), the R 4 Can be H, CN or CF 3 Monosubstitution, said R 3 And said R 4 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-; -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substitution and is such that the heteroatoms are not directly bonded, said R 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I.
Alternatively, in some embodiments of the invention, the compound represented by formula I is selected from one or more of the following compounds represented by the subformulae I-1 to I-8; the sub-formulae I-1 to I-8 are in particular:
Figure BDA0003934638260000031
wherein n is 0,1,2,3,4 or 5;
L 1 、L 2 、L 3 、L 4 、L 5 、L 6 、L 7 and L 8 Each independently of the other is H or F.
Alternatively, in some embodiments of the invention, the compound represented by formula I is selected from one or more of the following compounds represented by sub-formulae I-a to I-r, in particular sub-formulae I-1 a to I-1I:
Figure BDA0003934638260000041
alternatively, in some embodiments of the invention, the compound represented by formula II is selected from one or more of the following compounds represented by sub-formulae II-1 to II-12, and in particular sub-formulae II-1 to II-12:
Figure BDA0003934638260000042
optionally, in some embodiments of the present invention, the liquid crystal composition further comprises one or more compounds represented by formula iii, specifically:
Figure BDA0003934638260000043
wherein p is 0,1 or 2;
Z 5 and Z 6 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; z is 5 And said Z 6 One or more of H in (a) may be substituted by F, cl, br, I;
R 5 and R 6 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 5 The terminal group of (1), the R 6 Can be H, CN or CF 3 Monosubstitution, said R 5 And said R 6 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O-、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 5 The R is 6 One or more of H in (a) may be substituted by F, cl, br, I;
Figure BDA0003934638260000051
and each one of
Figure BDA0003934638260000052
Each independently of the other is
Figure BDA0003934638260000053
Figure BDA0003934638260000054
Figure BDA0003934638260000055
The above-mentioned
Figure BDA0003934638260000056
The above-mentioned
Figure BDA0003934638260000057
And each of said
Figure BDA0003934638260000058
One or more of H in (b) may be substituted by F, cl, br.
Alternatively, in some embodiments of the invention, the compound represented by formula iii is selected from one or more of the following compounds represented by subformulae iii-1 to iii-5, specifically subformulae iii-1 to iii-5:
Figure BDA0003934638260000059
optionally, in some embodiments of the present invention, the liquid crystal composition further comprises one or more compounds represented by formula iv, specifically:
Figure BDA00039346382600000510
wherein q is 0,1 or 2;
L 1 and L 2 Each independently of the others, is H, F, cl, br, CN, or an alkyl group having 1 to 5 carbon atoms, or an alkenyl or alkynyl group having 2 to 5 carbon atoms;
Z 7 and each Z 8 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; z is 7 And each of said Z 8 One or more of H in (a) may be substituted by F, cl, br, I;
R 7 and R 8 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 7 The terminal group of (1), the R 8 May be H, CN or CF 3 Monosubstitution, said R 7 And said R 8 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 7 The R is 8 One or more of H in (a) may be substituted by F, cl, br, I;
Figure BDA0003934638260000061
and each one of
Figure BDA0003934638260000062
Each independently of the other is
Figure BDA0003934638260000063
Figure BDA0003934638260000064
Figure BDA0003934638260000065
The above-mentioned
Figure BDA0003934638260000066
And each of said
Figure BDA0003934638260000067
One or more of H in (b) may be substituted by F, cl, br.
Alternatively, in some embodiments of the invention, the compound represented by formula IV is selected from one or more of the following compounds represented by sub-formulae IV-1 to IV-8, with sub-formulae IV-1 to IV-8 being specific:
Figure BDA0003934638260000071
alternatively, in some embodiments of the invention, the liquid crystal composition comprises
Figure BDA0003934638260000072
Figure BDA0003934638260000073
Figure BDA0003934638260000074
The above-mentioned
Figure BDA0003934638260000075
The above-mentioned
Figure BDA0003934638260000076
The described
Figure BDA0003934638260000077
The above-mentioned
Figure BDA0003934638260000078
The described
Figure BDA0003934638260000079
The described
Figure BDA00039346382600000710
The above-mentioned
Figure BDA00039346382600000711
The above-mentioned
Figure BDA00039346382600000712
The above-mentioned
Figure BDA00039346382600000713
The described
Figure BDA00039346382600000714
The above-mentioned
Figure BDA00039346382600000715
Respectively accounting for 18%, 11%, 5%, 12%, 8%, 6%, 7%, 13%; alternatively, the first and second electrodes may be,
the liquid crystal composition comprises
Figure BDA0003934638260000081
Figure BDA0003934638260000082
The described
Figure BDA0003934638260000083
The described
Figure BDA0003934638260000084
The above-mentioned
Figure BDA0003934638260000085
The above-mentioned
Figure BDA0003934638260000086
The above-mentioned
Figure BDA0003934638260000087
The described
Figure BDA0003934638260000088
The above-mentioned
Figure BDA0003934638260000089
The described
Figure BDA00039346382600000810
The described
Figure BDA00039346382600000811
The described
Figure BDA00039346382600000812
The described
Figure BDA00039346382600000813
35%, 5%, 10%, 8%, 4%, 10%, 6%, 8%, 2%; alternatively, the first and second electrodes may be,
the liquid crystal composition comprises
Figure BDA00039346382600000814
Figure BDA00039346382600000815
Figure BDA00039346382600000816
The above-mentioned
Figure BDA00039346382600000817
The above-mentioned
Figure BDA00039346382600000818
The above-mentioned
Figure BDA00039346382600000819
The described
Figure BDA00039346382600000820
The described
Figure BDA00039346382600000821
The described
Figure BDA00039346382600000822
The described
Figure BDA0003934638260000091
The described
Figure BDA0003934638260000092
The above-mentioned
Figure BDA0003934638260000093
The above-mentioned
Figure BDA0003934638260000094
The above-mentioned
Figure BDA0003934638260000095
The above-mentioned
Figure BDA0003934638260000096
The described
Figure BDA0003934638260000097
The described
Figure BDA0003934638260000098
The weight percentages of the components are respectively 10 percent, 5 percent and 9 percent 9%, 8%, 5%, 8%, 6%; alternatively, the first and second liquid crystal display panels may be,
the liquid crystal composition comprises
Figure BDA0003934638260000099
Figure BDA00039346382600000910
Figure BDA00039346382600000911
The described
Figure BDA00039346382600000912
The described
Figure BDA00039346382600000913
The above-mentioned
Figure BDA00039346382600000914
The described
Figure BDA00039346382600000915
The above-mentioned
Figure BDA00039346382600000916
The above-mentioned
Figure BDA00039346382600000917
The above-mentioned
Figure BDA00039346382600000918
The above-mentioned
Figure BDA00039346382600000919
The described
Figure BDA00039346382600000920
The above-mentioned
Figure BDA00039346382600000921
The mass percentages of the components are respectively 35%, 10%, 5%, 6%, 8%, 10%, 6% and 6%; alternatively, the first and second liquid crystal display panels may be,
the liquid crystal composition comprises
Figure BDA00039346382600000922
Figure BDA00039346382600000923
Figure BDA0003934638260000101
Figure BDA0003934638260000102
The above-mentioned
Figure BDA0003934638260000103
The described
Figure BDA0003934638260000104
The above-mentioned
Figure BDA0003934638260000105
The above-mentioned
Figure BDA0003934638260000106
The above-mentioned
Figure BDA0003934638260000107
The above-mentioned
Figure BDA0003934638260000108
The described
Figure BDA0003934638260000109
The above-mentioned
Figure BDA00039346382600001010
The above-mentioned
Figure BDA00039346382600001011
The above-mentioned
Figure BDA00039346382600001012
The above-mentioned
Figure BDA00039346382600001013
The above-mentioned
Figure BDA00039346382600001014
The described
Figure BDA00039346382600001015
The weight percentages of the components are respectively 35%, 3%, 5%, 3%, 8%, 9%, 8%, 6%, 4%, 6%, 5% and 3%; alternatively, the first and second liquid crystal display panels may be,
the liquid crystal composition comprises
Figure BDA00039346382600001016
Figure BDA00039346382600001017
Figure BDA00039346382600001018
The above-mentioned
Figure BDA00039346382600001019
The above-mentioned
Figure BDA00039346382600001020
The described
Figure BDA00039346382600001021
The described
Figure BDA00039346382600001022
The above-mentioned
Figure BDA00039346382600001023
The described
Figure BDA00039346382600001024
The above-mentioned
Figure BDA00039346382600001025
The above-mentioned
Figure BDA00039346382600001026
The above-mentioned
Figure BDA00039346382600001027
The above-mentioned
Figure BDA00039346382600001028
The mass percentages of the components are respectively 30%, 8%, 13%, 5%, 8%, 6%, 10% and 4%.
Correspondingly, the invention also provides a liquid crystal display panel, which comprises a first substrate, a second substrate and a liquid crystal layer, wherein the first substrate and the second substrate are oppositely arranged, the liquid crystal layer is arranged between the first substrate and the second substrate, and the liquid crystal layer comprises the liquid crystal composition disclosed by any embodiment of the invention.
The invention provides a liquid crystal composition and a liquid crystal display panel, wherein the liquid crystal composition comprises one or more than one
Figure BDA0003934638260000111
A compound represented by the formula (I), and one or more
Figure BDA0003934638260000112
A compound represented by the formula (I), and
Figure BDA0003934638260000113
the fluorophenyl group in (1) has greater dielectric negativity, and the compound has a structure
Figure BDA0003934638260000114
Has a low viscosity, the
Figure BDA0003934638260000115
And the above
Figure BDA0003934638260000116
The interaction makes the liquid crystal composition have the advantages of larger polarity, lower viscosity, quicker corresponding time and the like, and is favorable for the liquid crystal composition to adapt to a liquid crystal display device so as to improve various performances of the liquid crystal display device.
Drawings
The technical solution and other advantages of the present application will become apparent from the detailed description of the embodiments of the present application with reference to the accompanying drawings.
Fig. 1 is a schematic structural diagram of a liquid crystal display panel according to an embodiment of the invention.
Detailed Description
While the embodiments and/or examples of the present invention will be described in detail and fully with reference to the specific embodiments thereof, it should be understood that the embodiments and/or examples described below are only a part of the embodiments and/or examples of the present invention and are not intended to limit the scope of the invention. All other embodiments and/or examples, which can be obtained by a person skilled in the art without inventive step, are within the scope of protection of the present invention.
The directional terms used in the present invention, such as [ upper ], [ lower ], [ left ], [ right ], [ front ], [ rear ], [ inner ], [ outer ], [ side ], etc., refer only to the directions of the attached drawings. Accordingly, the directional terminology is used for purposes of illustration and understanding and is in no way limiting. The terms "first", "second", and the like are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first," "second," etc. may explicitly or implicitly include one or more of that feature.
The embodiment of the invention provides a liquid crystal composition and a liquid crystal display panel comprising the same, which are used for improving the performances of the liquid crystal display panel such as contrast, response time and the like.
In one embodiment, the liquid crystal composition comprises one or more compounds represented by formula I and one or more compounds represented by formula II.
The formula I is specifically as follows:
Figure BDA0003934638260000121
wherein m, n and o are each independently of the other 0,1 or 2, and m + n + o.ltoreq.4; preferably, m, n and o are independently of one another 0 or 1, and m + n + o.ltoreq.3; particularly preferably, m + n + o.ltoreq.2.
Each of Z 1 Each of Z 2 、Z 3 And each Z 4 Independently of one another, a single bond, -O-, -C (O))O-、-OC(O)-、-CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C.ident.C-, or alkyl ethers having 1 to 7 carbon atoms, or alkenyl, alkynyl or alkynyl ethers having 2 to 7 carbon atoms; preferably, each Z 1 Each Z 2 、Z 3 And each Z 4 Independently of one another, is a single bond, -O-) -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CH 2 O-or-OCH 2 Or an alkyl or alkyl ether having 1 to 7 carbon atoms; particularly preferably, each Z 1 Each Z 2 、Z 3 And each Z 4 Independently of one another, a single bond, or an alkyl or alkyl ether having 1 to 5 carbon atoms. Each Z 1 Each Z 2 、Z 3 And each Z 4 One or more of H in (b) may be substituted by F, cl, br, I.
R 1 And R 2 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 1 to 15 carbon atoms; preferably, said R is 1 And said R 2 Independently of one another, H, F, cl, br, or an alkyl or alkoxy group having 1 to 7 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 1 to 7 carbon atoms; particularly preferably, R is 1 And said R 2 Independently of one another, is an alkyl or alkoxy group having 1 to 5 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 5 carbon atoms. The R is 1 The terminal group of (1), the R 2 May be H, CN or CF 3 Monosubstitution, said R 1 And said R 2 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I.
Each one of which is
Figure BDA0003934638260000122
Each one of which is
Figure BDA0003934638260000123
And each one of
Figure BDA0003934638260000124
Each independently of the other is
Figure BDA0003934638260000125
Figure BDA0003934638260000126
Figure BDA0003934638260000127
And the above mentioned
Figure BDA0003934638260000128
The above-mentioned
Figure BDA0003934638260000129
The above-mentioned
Figure BDA0003934638260000131
The above-mentioned
Figure BDA0003934638260000132
And the above
Figure BDA0003934638260000133
At least one of which is
Figure BDA0003934638260000134
Preferably, each of said
Figure BDA0003934638260000135
Each of said
Figure BDA0003934638260000136
The above-mentioned
Figure BDA0003934638260000137
The described
Figure BDA0003934638260000138
And each of said
Figure BDA0003934638260000139
Independently of one another are
Figure BDA00039346382600001310
Figure BDA00039346382600001311
Particularly preferably, each of said
Figure BDA00039346382600001312
Each of said
Figure BDA00039346382600001313
The described
Figure BDA00039346382600001314
The described
Figure BDA00039346382600001315
And each of said
Figure BDA00039346382600001316
Independently of one another are
Figure BDA00039346382600001317
Each of said
Figure BDA00039346382600001318
Each of said
Figure BDA00039346382600001319
The described
Figure BDA00039346382600001320
The above-mentioned
Figure BDA00039346382600001321
And each of said
Figure BDA00039346382600001322
One or more of H in (b) may be substituted by F, cl, br.
The formula II is specifically as follows:
Figure BDA00039346382600001323
wherein R is 3 And R 4 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; preferably, said R is 3 And said R 4 Independently of one another, H, F, cl, br, or an alkyl or alkoxy group having 1 to 7 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 7 carbon atoms; particularly preferably, R is 3 And said R 4 Independently of one another, is an alkyl or alkoxy radical having 1 to 5 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy radical having 2 to 5 carbon atoms. The R is 3 The terminal group of (A), the R 4 May be H, CN or CF 3 Monosubstitution, said R 3 And said R 4 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substitution and is such that the heteroatoms are not directly bonded, said R 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I.
When said R is 1 The R is 2 The R is 3 And said R 4 When independently of one another, an alkyl group or an alkoxy group, the alkyl group or the alkoxy group may be straightA chain group, which may be branched, preferably a linear group; the linear group is a linear aliphatic hydrocarbon group and the branched group is a branched aliphatic hydrocarbon group. Preferably, said R is 1 The R is 2 R said 3 And said R 4 Independently of one another, methyl, ethyl, propyl, butyl, pentyl or hexyl.
When said R is 1 The R is 2 The R is 3 And said R 4 When independently an alkenyl group or an alkynyl group, the alkenyl group or the alkynyl group may be a straight chain group or a branched chain group, and the alkenyl group or the alkynyl group has at least one carbon-carbon double bond or carbon-carbon triple bond; preferably said R 1 The R is 2 The R is 3 And said R 4 Independently of one another, alkenyl or alkynyl having 2 to 7 carbon atoms, particularly preferably R 1 The R is 2 R said 3 And said R 4 Independently of one another, vinyl, prop-1-enyl, prop-2-enyl, but-1-enyl, but-2-enyl, but-3-enyl, pent-1-enyl, pent-2-enyl, pent-3-enyl, pent-4-enyl, hex-1-enyl, hex-2-enyl, hex-3-enyl, hex-4-enyl, hex-5-enyl, hept-1-enyl, hept-2-enyl, hept-3-enyl, hept-4-enyl, hept-5-enyl, hept-6-enyl, ethynyl, prop-1-ynyl, prop-2-ynyl, but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, hept-1-heptynyl, hept-2-ynyl, hex-3-4-ynyl, hex-4-heptynyl, hex-1-2-heptynyl, hex-5-heptynyl, hept-6-heptynyl and E-isomers. Of alkenyl and alkynyl groups, preferred is prop-2-enyl, but-3-enyl, pent-2-enyl, pent-3-enyl, pent-4-enyl, prop-2-ynyl, but-3-ynyl, pent-2-ynyl, pent-3-ynyl or pent-4-ynyl.
In one embodiment, the compound represented by formula I is selected from one or more of the following compounds represented by the sub-formulae I-1 to I-8; preferably, the compound represented by the formula I is selected from one or more of the compounds represented by the sub-formulae I-1, I-4 to I-8; particularly preferably, the compound represented by the formula I is selected from one or more of the compounds represented by the subformulae I-6 and I-7; the formulae I-1 to I-8 are in particular:
Figure BDA0003934638260000141
wherein n is 0,1,2,3,4 or 5; preferably, n is 0,1,2,3 or 4; particularly preferably, n is 1,2 or 3;
L 1 、L 2 、L 3 、L 4 、L 5 、L 6 、L 7 and L 8 Each independently of the other is H or F;
R 1 、R 2 each independently of the others, H, F, CN, or an alkyl or alkoxy group having 1 to 7 carbon atoms, or an alkenyl, alkenyloxy group having 2 to 7 carbon atoms; said R is 7 The terminal group of (1), the R 8 May be H, CN or CF 3 Monosubstitution, said R 1 And said R 2 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-; -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 1 The R is 2 One or more of H in (b) may be substituted by F, cl, br, I. R 1 Methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy are preferred, and methyl, ethyl, propyl, butyl, and pentyl are particularly preferred. R 2 Methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy, and particularly methoxy, ethoxy, propoxy, butoxy, and pentyloxy are preferable.
Preferably, the compound represented by the formula I is selected from one or more of the following compounds represented by the sub-formulae I-a to I-r; preferably, the compound represented by the formula I is selected from one or more of the compounds represented by the sub-formulae I-d to I-i and I-m to I-r; particularly preferably, the compound represented by the formula I is selected from one or more compounds represented by sub-formulae I-m to I-r; the sub-formulae I-a to I-r are in particular:
Figure BDA0003934638260000151
in one embodiment, the compound represented by formula II is selected from one or more of the following compounds represented by the sub-formulae II-1 to II-12; preferably, the compound represented by the formula II is selected from one or more compounds represented by the sub-formulae of the formulae II-1, II-2, II-10, II-11 and II-12; the sub-formulae II-1 to II-12 are specifically:
Figure BDA0003934638260000161
in one embodiment, the liquid crystal composition further comprises one or more of the compounds represented by formula iii, in particular:
Figure BDA0003934638260000162
wherein p is 0,1 or 2; preferably, p is 0 or 1.
Z 5 And Z 6 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; preferably, Z is 5 And said Z 6 Independently of one another, is a single bond, -O-) -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CH 2 O-or-OCH 2 -; particularly preferably, Z is 5 And said Z 6 Independently of one another, a single bond or-CH 2 O-is formed. Z is 5 And said Z 6 One or more of H in (b) may be substituted by F, cl, br, I.
R 5 And R 6 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; preferably, said R is 5 And said R 6 Independently of one another, H, F, cl, br, or an alkyl or alkoxy group having 1 to 7 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 7 carbon atoms; particularly preferably, R is 5 And said R 6 Independently of one another, is an alkyl or alkoxy group having 1 to 5 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 5 carbon atoms. Said R is 5 The terminal group of (1), the R 6 May be H, CN or CF 3 Monosubstitution, said R 5 And said R 6 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O-、-OCH 2 -, -CH = CH-or-C ≡ C-substitution and is such that the heteroatoms are not directly bonded, said R 5 R said 6 One or more of H in (a) may be substituted by F, cl, br, I.
Figure BDA0003934638260000171
And each one of
Figure BDA0003934638260000172
Each independently of the other is
Figure BDA0003934638260000173
Figure BDA0003934638260000174
Figure BDA0003934638260000175
Preferably, the
Figure BDA0003934638260000176
The described
Figure BDA0003934638260000177
And each of said
Figure BDA0003934638260000178
Independently of one another are
Figure BDA0003934638260000179
Figure BDA00039346382600001710
Particularly preferably, the
Figure BDA00039346382600001711
The described
Figure BDA00039346382600001712
And each of said
Figure BDA00039346382600001713
Independently of one another are
Figure BDA00039346382600001714
The described
Figure BDA00039346382600001715
The described
Figure BDA00039346382600001716
And each of said
Figure BDA00039346382600001717
One or more of H in (a) may be substituted by F, cl, br.
In one embodiment, the compound represented by formula III is selected from one or more of the following compounds represented by sub-formulae III-1 to III-5; the sub-formulae III-1 to III-5 are specifically:
Figure BDA00039346382600001718
wherein R is 5 Preferred are methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy, ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, and particularly preferred are methyl, ethyl, propyl, butyl and pentyl. R 2 Preferably methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy, ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, particularly preferably methyl, ethyl, propyl, butyl, pentyl, ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl.
Preferably, the compound represented by the formula III is selected from one or more of the following compounds represented by the sub-formulae III-1 a to III-5 e; the sub-formulae III-1 a to III-5 e are in particular:
Figure BDA0003934638260000181
in one embodiment, the liquid crystal composition further comprises one or more compounds represented by formula iv, in particular:
Figure BDA0003934638260000182
wherein q is 0,1 or 2; preferably, q is 0 or 1.
L 1 And L 2 Each independently of the others, being H, F, cl, br, CN, or an alkyl group having 1 to 5 carbon atoms, or an alkenyl or alkynyl group having 2 to 5 carbon atoms; preferably, said L 1 And said L 2 Are all F.
Z 7 And each Z 8 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; preferably, Z is 7 And each of said Z 8 Independently of one another, is a single bond, -O-) -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CH 2 O-or-OCH 2 -; particularly preferably, Z is 7 And each of said Z 8 Independently of one another, a single bond or-CH 2 O-is formed. Z is 7 And each of said Z 8 One or more of H in (b) may be substituted by F, cl, br, I.
R 7 And R 8 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; preferably, said R is 7 And said R 8 Independently of one another, H, F, cl, br, or an alkyl or alkoxy group having 1 to 7 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 7 carbon atoms; particularly preferably, R is 7 And said R 8 Independently of one another, is an alkyl or alkoxy group having 1 to 5 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 5 carbon atoms. The R is 7 The terminal group of (A), the R 8 May be H, CN or CF 3 Monosubstitution, said R 7 And said R 8 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 7 The R is 8 One or more of H in (b) may be substituted by F, cl, br, I.
Figure BDA0003934638260000191
And each one of
Figure BDA0003934638260000192
Each independently of the other is
Figure BDA0003934638260000193
Figure BDA0003934638260000194
Figure BDA0003934638260000195
Preferably, the
Figure BDA0003934638260000196
And each of said
Figure BDA0003934638260000197
Independently of one another are
Figure BDA0003934638260000198
Figure BDA0003934638260000199
Particularly preferably, the
Figure BDA00039346382600001910
And each of said
Figure BDA00039346382600001911
Independently of one another are
Figure BDA00039346382600001912
The described
Figure BDA00039346382600001913
And each of said
Figure BDA00039346382600001914
One or more of H in (a) may be substituted by F, cl, br.
In one embodiment, the compound represented by formula IV is selected from one or more of the following compounds represented by the sub-formulae IV-1 to IV-8; the sub-formulae IV-1 to IV-8 are specifically:
Figure BDA00039346382600001915
wherein R is 7 Methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy are preferred, and methyl, ethyl, propyl, butyl, and pentyl are particularly preferred. R is 8 Methyl, methoxy, ethyl, ethoxy, propyl, propoxy, butyl, butoxy, pentyl, pentyloxy, and particularly methoxy, ethoxy, propoxy, butoxy, pentyloxy, are preferable.
Preferably, the compound represented by the formula IV is selected from one or more of the following compounds represented by the sub-formulae IV-1 a to IV-8 g; the sub-formulas IV-1 a to IV-8 g are specifically as follows:
Figure BDA0003934638260000201
in one embodiment, the weight percentages of the compound represented by formula i, the compound represented by formula ii, the compound represented by formula iii, and the compound represented by formula iv are 1% to 50%, 1% to 95%, 0% to 90%, and 0% to 90%, respectively. Preferably, the weight percentages of the compound represented by the formula I, the compound represented by the formula II, the compound represented by the formula III and the compound represented by the formula IV are 1% -40%, 5% -70% and 5% -70%, respectively. More preferably, the weight percentages of the compound represented by the formula I, the compound represented by the formula II, the compound represented by the formula III and the compound represented by the formula IV are 1% -20%, 10% -50% and 10% -50%, respectively.
Hereinafter, the liquid crystal composition provided by the present invention will be explained in detail by specific examples.
Example one
TABLE 1
Figure BDA0003934638260000211
Referring to table 1, table 1 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this example, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000212
Figure BDA0003934638260000213
The described
Figure BDA0003934638260000221
The above-mentioned
Figure BDA0003934638260000222
The described
Figure BDA0003934638260000223
The above-mentioned
Figure BDA0003934638260000224
The described
Figure BDA0003934638260000225
The above-mentioned
Figure BDA0003934638260000226
The described
Figure BDA0003934638260000227
The above-mentioned
Figure BDA0003934638260000228
The described
Figure BDA0003934638260000229
The above-mentioned
Figure BDA00039346382600002210
The above-mentioned
Figure BDA00039346382600002211
The weight percentages of (A) and (B) are respectively 18%, 11%, 5%, 12%, 8%, 6%, 7% and 13%.
Response time of liquid crystal
Figure BDA00039346382600002212
Wherein gamma 1 is the rotational viscosity of the liquid crystal material, d is the thickness of the liquid crystal box, delta epsilon is the dielectric anisotropy of the liquid crystal, and V th For the threshold voltage, K11 is the splay elastic coefficient, K22 is the twist elastic coefficient, and K33 is the bend elastic coefficient. From the above formula, the response time of the liquid crystal is positively correlated with the rotational viscosity γ 1, and negatively correlated with the dielectric anisotropy Δ ∈ and the splay elastic coefficient K11 and the bend elastic coefficient K33. The liquid crystal composition provided in this example had a rotational viscosity γ 1 of 98 mPas, a dielectric anisotropy Δ ε of-3.6, a splay elastic coefficient K11 of 15.2, and a bend elastic coefficient K33 of 16.1. The liquid crystal composition provided by the application has a large negative dielectric constant delta epsilon, a small rotational viscosity gamma 1, a large splay elastic coefficient K11 and a large bending elastic coefficient K33, so that the liquid crystal composition has a fast response time and is beneficial to improving the response speed of a liquid crystal display panel.
The contrast of liquid crystals is related to the dielectric anisotropy of liquid crystals, and a negative dielectric anisotropy contributes to the improvement of the contrast of liquid crystals. The compound represented by the formula I has larger negative polarity, and the liquid crystal composition has larger negative dielectric constant delta epsilon by adding the compound represented by the formula I into the liquid crystal composition, thereby being beneficial to improving the contrast of a liquid crystal display panel.
In addition, the liquid crystal composition provided by the embodiment has a higher clearing point Tni (100 ℃), so that the liquid crystal composition has a wider working temperature range and a higher maximum working temperature. The liquid crystal composition has a large negative dielectric constant Deltaepsilon (-3.6) at a temperature of 25 ℃ and a low driving voltage.
In the liquid crystal composition provided in this embodiment, the compound represented by formula i has a larger dielectric negativity and a lower rotational viscosity, and the addition of the compound helps to shorten the response time of the liquid crystal and improve the contrast of the liquid crystal composition; the compound represented by the formula II has the characteristics of dielectric neutrality and low viscosity, and the addition of the compound also helps to shorten the response time of liquid crystal; the compound represented by the formula III has dielectric negativity, high Tni characteristics and the like; the compounds represented by the formulas I, II and III in the liquid crystal composition can be properly adjusted according to actual needs so as to adjust various properties of the liquid crystal composition.
In summary, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, which is beneficial to improving the response speed and the contrast of the liquid crystal display panel, and simultaneously reducing the driving voltage of the liquid crystal display panel, expanding the working temperature range of the liquid crystal display panel and improving the highest working temperature of the liquid crystal display panel.
The preparation method of the liquid crystal composition comprises the following steps:
step B1, weighing the predetermined weight of the mixture according to the weight percentages of 18%, 11%, 5%, 12%, 8%, 6%, 7% and 13%
Figure BDA0003934638260000231
The described
Figure BDA0003934638260000232
The described
Figure BDA0003934638260000233
The above-mentioned
Figure BDA0003934638260000234
The above-mentioned
Figure BDA0003934638260000235
The described
Figure BDA0003934638260000236
The described
Figure BDA0003934638260000237
The described
Figure BDA0003934638260000238
The described
Figure BDA0003934638260000239
The described
Figure BDA00039346382600002310
The described
Figure BDA00039346382600002311
B2, sequentially adding the compounds into a melting container according to the sequence of melting points from low to high, heating and stirring at the temperature of 60-100 ℃ to fully dissolve and mix the liquid crystal composition;
and B3, cooling the liquid crystal composition to room temperature.
Example two
TABLE 2
Figure BDA0003934638260000241
Referring to table 2, table 2 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this embodiment, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000242
Figure BDA0003934638260000243
The above-mentioned
Figure BDA0003934638260000244
The described
Figure BDA0003934638260000245
The described
Figure BDA0003934638260000246
The described
Figure BDA0003934638260000247
The above-mentioned
Figure BDA0003934638260000248
The above-mentioned
Figure BDA0003934638260000249
The above-mentioned
Figure BDA00039346382600002410
The described
Figure BDA00039346382600002411
The above-mentioned
Figure BDA0003934638260000251
The described
Figure BDA0003934638260000252
The described
Figure BDA0003934638260000253
Respectively 35%, 5%, 10%, 8%, 4%, 10%, 6%, 8%, 2%.
Similarly, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, and is beneficial to improving the response speed and the contrast of the liquid crystal display panel, reducing the driving voltage of the liquid crystal display panel, expanding the working temperature range of the liquid crystal display panel and improving the highest working temperature of the liquid crystal display panel.
EXAMPLE III
TABLE 3
Figure BDA0003934638260000261
Referring to table 3, table 3 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this embodiment, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000262
Figure BDA0003934638260000271
Figure BDA0003934638260000272
The above-mentioned
Figure BDA0003934638260000273
The above-mentioned
Figure BDA0003934638260000274
The above-mentioned
Figure BDA0003934638260000275
The described
Figure BDA0003934638260000276
The described
Figure BDA0003934638260000277
The described
Figure BDA0003934638260000278
The above-mentioned
Figure BDA0003934638260000279
The above-mentioned
Figure BDA00039346382600002710
The above-mentioned
Figure BDA00039346382600002711
The above-mentioned
Figure BDA00039346382600002712
The described
Figure BDA00039346382600002713
The above-mentioned
Figure BDA00039346382600002714
The above-mentioned
Figure BDA00039346382600002715
The described
Figure BDA00039346382600002716
The weight percentages of the components are respectively 10 percent, 5 percent and 9 percent 9%, 8%, 5%, 8%, 6%.
Similarly, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, so that the response speed and the contrast of the liquid crystal display panel are favorably improved, the driving voltage of the liquid crystal display panel is reduced, the working temperature range of the liquid crystal display panel is expanded, and the highest working temperature of the liquid crystal display panel is improved.
Example four
TABLE 4
Figure BDA0003934638260000281
Referring to table 4, table 4 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this example, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000282
Figure BDA0003934638260000283
The described
Figure BDA0003934638260000284
The above-mentioned
Figure BDA0003934638260000285
The above-mentioned
Figure BDA0003934638260000286
The above-mentioned
Figure BDA0003934638260000287
The above-mentioned
Figure BDA0003934638260000288
The described
Figure BDA0003934638260000289
The above-mentioned
Figure BDA00039346382600002810
The described
Figure BDA0003934638260000291
The above-mentioned
Figure BDA0003934638260000292
The above-mentioned
Figure BDA0003934638260000293
The mass percentages of the components are respectively 35%, 10%, 5%, 6%, 8%, 10%, 6% and 6%.
Similarly, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, and is beneficial to improving the response speed and the contrast of the liquid crystal display panel, reducing the driving voltage of the liquid crystal display panel, expanding the working temperature range of the liquid crystal display panel and improving the highest working temperature of the liquid crystal display panel.
EXAMPLE five
TABLE 5
Figure BDA0003934638260000301
Referring to table 5, table 5 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this example, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000302
Figure BDA0003934638260000303
The described
Figure BDA0003934638260000311
The described
Figure BDA0003934638260000312
The above-mentioned
Figure BDA0003934638260000313
The above-mentioned
Figure BDA0003934638260000314
The described
Figure BDA0003934638260000315
The above-mentioned
Figure BDA0003934638260000316
The above-mentioned
Figure BDA0003934638260000317
The described
Figure BDA0003934638260000318
The described
Figure BDA0003934638260000319
The above-mentioned
Figure BDA00039346382600003110
The described
Figure BDA00039346382600003111
The described
Figure BDA00039346382600003112
The above-mentioned
Figure BDA00039346382600003113
Respectively 35%, 3%, 5%, 3%, 8%, 9%, 8%, 6%, 4%, 6%, 5%, 3%.
Similarly, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, so that the response speed and the contrast of the liquid crystal display panel are favorably improved, the driving voltage of the liquid crystal display panel is reduced, the working temperature range of the liquid crystal display panel is expanded, and the highest working temperature of the liquid crystal display panel is improved.
Example six
TABLE 6
Figure BDA0003934638260000321
Referring to table 6, table 6 shows the mixture ratio of the compounds of each component of the liquid crystal composition provided in this example, and the performance parameters of the liquid crystal composition. The liquid crystal composition comprises
Figure BDA0003934638260000322
Figure BDA0003934638260000323
The described
Figure BDA0003934638260000324
The described
Figure BDA0003934638260000325
The described
Figure BDA0003934638260000326
The above-mentioned
Figure BDA0003934638260000327
The above-mentioned
Figure BDA0003934638260000328
The described
Figure BDA0003934638260000329
The above-mentioned
Figure BDA00039346382600003210
The above-mentioned
Figure BDA00039346382600003211
The described
Figure BDA00039346382600003212
The described
Figure BDA00039346382600003213
The mass percentages of (A) and (B) are respectively 30%, 8%, 13%, 5%, 8%, 6%, 10% and 4%.
Similarly, the liquid crystal composition provided by the embodiment has a larger dielectric negativity, a smaller rotational viscosity, a larger splay elastic coefficient, a larger bending elastic coefficient, a larger vertical dielectric constant and a higher clearing point, so that the response speed and the contrast of the liquid crystal display panel are favorably improved, the driving voltage of the liquid crystal display panel is reduced, the working temperature range of the liquid crystal display panel is expanded, and the highest working temperature of the liquid crystal display panel is improved.
Referring to fig. 1, the present invention further provides a liquid crystal display panel, where the liquid crystal display panel includes a first substrate 11, a second substrate 12, and a liquid crystal layer 13, the first substrate 11 and the second substrate 12 are disposed opposite to each other, the liquid crystal layer 13 is disposed between the first substrate 11 and the second substrate 12, and the liquid crystal layer 13 includes the liquid crystal composition according to any one of the embodiments of the present invention. Since the liquid crystal display panel includes the liquid crystal composition according to any one of the embodiments of the present invention, the liquid crystal display panel has the technical features and the advantages of the liquid crystal composition according to any one of the embodiments of the present invention. The Liquid Crystal display panel provided In the embodiment of the present invention may be any one of a Vertical Alignment (VA) Liquid Crystal display panel, a Birefringence Controlled (ECB) Liquid Crystal display panel, a Plasma Addressed Liquid Crystal display Panel (PALC), a Fringe Field Switching (FFS) Liquid Crystal display panel, an In-Plane Switching (IPS) Liquid Crystal display panel, and the like.
In summary, embodiments of the present invention provide a liquid crystal composition and a liquid crystal display panel, where the liquid crystal composition includes one or more kinds of liquid crystal materials
Figure BDA0003934638260000331
A compound represented by (I), and one or more
Figure BDA0003934638260000332
A compound represented by the formula
Figure BDA0003934638260000333
The fluorophenyl group in (1) has greater dielectric negativity, and the compound has a structure
Figure BDA0003934638260000334
Has a low viscosity, the
Figure BDA0003934638260000335
And said
Figure BDA0003934638260000336
The interaction makes the liquid crystal composition have the advantages of larger polarity, lower viscosity, quicker corresponding time and the like, is favorable for the liquid crystal composition to be adapted to a liquid crystal display device so as to improve the liquid crystal display deviceVarious properties of the device.
The liquid crystal composition and the liquid crystal display panel provided by the embodiments of the present invention are described in detail above, and the principles and embodiments of the present invention are explained herein by applying specific examples, and the above description of the embodiments is only used to help understanding the method and the core concept of the present invention; meanwhile, for those skilled in the art, according to the idea of the present invention, the specific embodiments and the application range may be changed, and in summary, the content of the present specification should not be construed as limiting the present invention.

Claims (10)

1. A liquid crystal composition comprising one or more compounds represented by formula i and one or more compounds represented by formula ii;
the formula I is specifically as follows:
Figure FDA0003934638250000011
wherein m, n and o are each independently of the other 0,1 or 2, and m + n + o.ltoreq.4;
each Z 1 Each Z 2 、Z 3 And each Z 4 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-, or an alkyl or alkyl ether having 1 to 7 carbon atoms, or an alkenyl, alkenyl ether, alkynyl or alkynyl ether having 2 to 7 carbon atoms; each of Z 1 Each Z 2 、Z 3 And each Z 4 One or more of H in (a) may be substituted by F, cl, br, I;
R 1 and R 2 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 1 to 15 carbon atoms; the R is 1 The terminal group of (A), the R 2 Can be H, CN or CF 3 Monosubstitution, said R 1 And said R 2 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substitution and is such that the heteroatoms are not directly bonded, said R 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I;
each one of which is
Figure FDA0003934638250000012
Each one of which is
Figure FDA0003934638250000013
And each one of
Figure FDA0003934638250000014
Each independently of the other is
Figure FDA0003934638250000015
Figure FDA0003934638250000016
Figure FDA0003934638250000017
And the above mentioned
Figure FDA0003934638250000018
The above-mentioned
Figure FDA0003934638250000019
The above-mentioned
Figure FDA00039346382500000110
The above-mentioned
Figure FDA00039346382500000111
And said
Figure FDA00039346382500000112
At least one of which is
Figure FDA00039346382500000113
Each of said
Figure FDA00039346382500000114
Each of said
Figure FDA00039346382500000115
The described
Figure FDA00039346382500000116
The described
Figure FDA00039346382500000117
And each of said
Figure FDA00039346382500000118
One or more of H in (a) may be substituted by F, cl, br;
the formula II is specifically as follows:
Figure FDA00039346382500000119
wherein R is 3 And R 4 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 3 The terminal group of (1), the R 4 Can be H, CN or CF 3 Monosubstitution, said R 3 And said R 4 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-; -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 1 The R is 2 One or more of H in (a) may be substituted by F, cl, br, I.
2. The liquid crystal composition as claimed in claim 1, wherein the compound represented by formula I is selected from one or more compounds represented by the following sub-formulae I-1 to I-8; the sub-formulae I-1 to I-8 are in particular:
Figure FDA0003934638250000021
wherein n is 0,1,2,3,4 or 5;
L 1 、L 2 、L 3 、L 4 、L 5 、L 6 、L 7 and L 8 Each independently of the other is H or F.
3. The liquid-crystal composition as claimed in claim 2, wherein the compound represented by formula I is selected from one or more of the following compounds represented by the sub-formulae I-a to I-r, in particular of the sub-formulae I-1 a to I-1I:
Figure FDA0003934638250000031
4. the liquid crystal composition as claimed in claim 1, wherein the compound represented by the formula ii is selected from one or more of the following compounds represented by sub-formulae ii-1 to ii-12, and the sub-formulae ii-1 to ii-12 are specifically:
Figure FDA0003934638250000032
5. the liquid crystal composition of claim 1, further comprising one or more compounds represented by formula iii, in particular:
Figure FDA0003934638250000033
wherein p is 0,1 or 2;
Z 5 and Z 6 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; z is 5 And said Z 6 One or more of H in (a) may be substituted by F, cl, br, I;
R 5 and R 6 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 5 The terminal group of (A), the R 6 May be H, CN or CF 3 Monosubstitution, said R 5 And said R 6 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-; -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O-、-OCH 2 -, -CH = CH-or-C ≡ C-substituted and having heteroatoms not directly bonded, said R being 5 The R is 6 One or more of H in (a) may be substituted by F, cl, br, I;
Figure FDA0003934638250000041
and each one of
Figure FDA0003934638250000042
Each independently of the other is
Figure FDA0003934638250000043
Figure FDA0003934638250000044
Figure FDA0003934638250000045
The above-mentioned
Figure FDA0003934638250000046
The described
Figure FDA0003934638250000047
And each of said
Figure FDA0003934638250000048
One or more of H in (a) may be substituted by F, cl, br.
6. The liquid crystal composition according to claim 5, wherein the compound represented by the formula III is selected from one or more of the following compounds represented by the sub-formulae III-1 to III-5, and the sub-formulae III-1 to III-5 are specifically:
Figure FDA0003934638250000049
7. the liquid crystal composition of claim 1, further comprising one or more compounds represented by formula iv, in particular:
Figure FDA00039346382500000410
wherein q is 0,1 or 2;
L 1 and L 2 Each independently of the others being H, F, cl, br, CN, or an alkyl group having 1 to 5 carbon atoms, or an alkenyl or alkynyl group having 2 to 5 carbon atomsA base;
Z 7 and each Z 8 Independently of one another, is a single bond, -O-,; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-; z is 7 And each of said Z 8 One or more of H in (a) may be substituted by F, cl, br, I;
R 7 and R 8 Independently of one another, H, F, cl, br, I, CN, SCN, NCS, SF 5 Or an alkyl or alkoxy group having 1 to 15 carbon atoms, or an alkenyl, alkenyloxy, alkynyl or alkynyloxy group having 2 to 15 carbon atoms; the R is 7 The terminal group of (1), the R 8 Can be H, CN or CF 3 Monosubstitution, said R 7 And said R 8 In one or more CH 2 The radicals being optionally substituted by-O-, -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substitution and is such that the heteroatoms are not directly bonded, said R 7 The R is 8 One or more of H in (a) may be substituted by F, cl, br, I;
Figure FDA0003934638250000051
and each one of
Figure FDA0003934638250000052
Each independently of the other is
Figure FDA0003934638250000053
Figure FDA0003934638250000054
Figure FDA0003934638250000055
The described
Figure FDA0003934638250000056
And each of said
Figure FDA0003934638250000057
One or more of H in (a) may be substituted by F, cl, br.
8. The liquid crystal composition according to claim 7, wherein the compound represented by the formula iv is selected from one or more of the following compounds represented by sub-formulae iv-1 to iv-8, and the sub-formulae iv-1 to iv-8 are specifically:
Figure FDA0003934638250000061
9. the liquid crystal composition of claim 1, wherein the liquid crystal composition comprises
Figure FDA0003934638250000062
Figure FDA0003934638250000063
The described
Figure FDA0003934638250000064
The above-mentioned
Figure FDA0003934638250000065
The above-mentioned
Figure FDA0003934638250000066
The described
Figure FDA0003934638250000067
The described
Figure FDA0003934638250000068
The described
Figure FDA0003934638250000069
The described
Figure FDA00039346382500000610
The above-mentioned
Figure FDA00039346382500000611
The above-mentioned
Figure FDA00039346382500000612
The above-mentioned
Figure FDA00039346382500000613
The described
Figure FDA00039346382500000614
The weight percentages of the components are respectively 18%, 11%, 5%, 12%, 8%, 6%, 7% and 13%; alternatively, the first and second electrodes may be,
the liquid crystal composition comprises
Figure FDA0003934638250000071
Figure FDA0003934638250000072
Figure FDA0003934638250000073
The above-mentioned
Figure FDA0003934638250000074
The described
Figure FDA0003934638250000075
The described
Figure FDA0003934638250000076
The above-mentioned
Figure FDA0003934638250000077
The above-mentioned
Figure FDA0003934638250000078
The described
Figure FDA0003934638250000079
The above-mentioned
Figure FDA00039346382500000710
The above-mentioned
Figure FDA00039346382500000711
The described
Figure FDA00039346382500000712
The described
Figure FDA00039346382500000713
The described
Figure FDA00039346382500000714
35%, 5%, 10%, 8%, 4%, 10%, 6%, 8%, 2%; alternatively, the first and second electrodes may be,
the liquid crystal composition comprises
Figure FDA00039346382500000715
Figure FDA00039346382500000716
Figure FDA00039346382500000717
The above-mentioned
Figure FDA00039346382500000718
The above-mentioned
Figure FDA00039346382500000719
The above-mentioned
Figure FDA00039346382500000720
The above-mentioned
Figure FDA00039346382500000721
The above-mentioned
Figure FDA00039346382500000722
The described
Figure FDA00039346382500000723
The above-mentioned
Figure FDA00039346382500000724
The described
Figure FDA00039346382500000725
The above-mentioned
Figure FDA0003934638250000081
The described
Figure FDA0003934638250000082
The described
Figure FDA0003934638250000083
The above-mentioned
Figure FDA0003934638250000084
The described
Figure FDA0003934638250000085
The above-mentioned
Figure FDA0003934638250000086
The weight percentages of the components are respectively 10 percent, 5 percent and 9 percent 9%, 8%, 5%, 8%, 6%; alternatively, the first and second liquid crystal display panels may be,
the liquid crystalThe composition comprises
Figure FDA0003934638250000087
Figure FDA0003934638250000088
Figure FDA0003934638250000089
The above-mentioned
Figure FDA00039346382500000810
The described
Figure FDA00039346382500000811
The described
Figure FDA00039346382500000812
The described
Figure FDA00039346382500000813
The described
Figure FDA00039346382500000814
The above-mentioned
Figure FDA00039346382500000815
The above-mentioned
Figure FDA00039346382500000816
The above-mentioned
Figure FDA00039346382500000817
The described
Figure FDA00039346382500000818
The above-mentioned
Figure FDA00039346382500000819
Respectively 35%, 10%, 5%, 6%, 8%Percent, 8 percent, 10 percent, 6 percent and 6 percent; alternatively, the first and second liquid crystal display panels may be,
the liquid crystal composition comprises
Figure FDA00039346382500000820
Figure FDA00039346382500000821
Figure FDA0003934638250000091
The described
Figure FDA0003934638250000092
The described
Figure FDA0003934638250000093
The above-mentioned
Figure FDA0003934638250000094
The described
Figure FDA0003934638250000095
The described
Figure FDA0003934638250000096
The above-mentioned
Figure FDA0003934638250000097
The above-mentioned
Figure FDA0003934638250000098
The above-mentioned
Figure FDA0003934638250000099
The above-mentioned
Figure FDA00039346382500000910
The above-mentioned
Figure FDA00039346382500000911
The described
Figure FDA00039346382500000912
The described
Figure FDA00039346382500000913
The above-mentioned
Figure FDA00039346382500000914
35%, 3%, 5%, 3%, 8%, 9%, 8%, 6%, 4%, 6%, 5%, 3% by weight, respectively; alternatively, the first and second liquid crystal display panels may be,
the liquid crystal composition comprises
Figure FDA00039346382500000915
Figure FDA00039346382500000916
Figure FDA00039346382500000917
Figure FDA00039346382500000918
The above-mentioned
Figure FDA00039346382500000919
The above-mentioned
Figure FDA00039346382500000920
The above-mentioned
Figure FDA00039346382500000921
The above-mentioned
Figure FDA00039346382500000922
The described
Figure FDA00039346382500000923
The described
Figure FDA00039346382500000924
The above-mentioned
Figure FDA00039346382500000925
The above-mentioned
Figure FDA00039346382500000926
The above-mentioned
Figure FDA00039346382500000927
The described
Figure FDA00039346382500000928
The mass percentages of the components are respectively 30%, 8%, 13%, 5%, 8%, 6%, 10% and 4%.
10. A liquid crystal display panel comprising a first substrate, a second substrate, and a liquid crystal layer, wherein the first substrate and the second substrate are disposed opposite to each other, the liquid crystal layer is disposed between the first substrate and the second substrate, and the liquid crystal layer comprises the liquid crystal composition according to any one of claims 1 to 9.
CN202211400148.5A 2022-11-09 2022-11-09 Liquid crystal composition and liquid crystal display panel Pending CN115710514A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211400148.5A CN115710514A (en) 2022-11-09 2022-11-09 Liquid crystal composition and liquid crystal display panel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211400148.5A CN115710514A (en) 2022-11-09 2022-11-09 Liquid crystal composition and liquid crystal display panel

Publications (1)

Publication Number Publication Date
CN115710514A true CN115710514A (en) 2023-02-24

Family

ID=85232680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211400148.5A Pending CN115710514A (en) 2022-11-09 2022-11-09 Liquid crystal composition and liquid crystal display panel

Country Status (1)

Country Link
CN (1) CN115710514A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101980996A (en) * 2008-04-09 2011-02-23 智索株式会社 Tricyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display device
CN103666485A (en) * 2013-12-04 2014-03-26 石家庄诚志永华显示材料有限公司 Negative dielectric anisotropic liquid crystal composition
CN105518105A (en) * 2013-09-06 2016-04-20 Dic株式会社 Nematic liquid crystal composition and liquid crystal display element using same
CN108384558A (en) * 2018-03-20 2018-08-10 晶美晟光电材料(南京)有限公司 A kind of negative type liquid crystal compound, the liquid crystal compound comprising the liquid-crystal compounds and its application
US20180244996A1 (en) * 2017-02-27 2018-08-30 Jnc Corporation Liquid crystal composition and liquid crystal display device
CN108559527A (en) * 2018-06-05 2018-09-21 晶美晟光电材料(南京)有限公司 A kind of liquid-crystal composition and its application with high-penetration rate
CN109407384A (en) * 2017-08-17 2019-03-01 江苏和成显示科技有限公司 Polymer network liquid crystal light modulation device
CN114920631A (en) * 2021-02-03 2022-08-19 杰科达谘询有限公司 Compound, liquid crystal composition containing compound, and liquid crystal display element using liquid crystal composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101980996A (en) * 2008-04-09 2011-02-23 智索株式会社 Tricyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display device
CN105518105A (en) * 2013-09-06 2016-04-20 Dic株式会社 Nematic liquid crystal composition and liquid crystal display element using same
CN103666485A (en) * 2013-12-04 2014-03-26 石家庄诚志永华显示材料有限公司 Negative dielectric anisotropic liquid crystal composition
US20180244996A1 (en) * 2017-02-27 2018-08-30 Jnc Corporation Liquid crystal composition and liquid crystal display device
CN109407384A (en) * 2017-08-17 2019-03-01 江苏和成显示科技有限公司 Polymer network liquid crystal light modulation device
CN108384558A (en) * 2018-03-20 2018-08-10 晶美晟光电材料(南京)有限公司 A kind of negative type liquid crystal compound, the liquid crystal compound comprising the liquid-crystal compounds and its application
CN108559527A (en) * 2018-06-05 2018-09-21 晶美晟光电材料(南京)有限公司 A kind of liquid-crystal composition and its application with high-penetration rate
CN114920631A (en) * 2021-02-03 2022-08-19 杰科达谘询有限公司 Compound, liquid crystal composition containing compound, and liquid crystal display element using liquid crystal composition

Similar Documents

Publication Publication Date Title
JP5497249B2 (en) Liquid crystal medium and electro-optic display including the same
TWI573789B (en) Compounds and liquid-crystalline medium
TWI607078B (en) Liquid-crystalline medium, method for the stabilisation thereof, and liquid-crystal display
TWI639685B (en) Liquid-crystal medium, and electro-optical display containing same
KR101457281B1 (en) Liquid crystal medium and electrooptical display containing same
TWI674312B (en) Liquid crystalline medium and liquid crystal display
TWI626300B (en) Liquid-crystalline medium and liquid-crystal display
JP5098355B2 (en) Polymerizable liquid crystal composition
TWI486426B (en) Liquid crystal composition and display device
CN115710514A (en) Liquid crystal composition and liquid crystal display panel
TWI541333B (en) Liquid-crystalline medium and liquid-crystal display
CN115746871A (en) Liquid crystal composition and liquid crystal display panel
CN115785971A (en) Liquid crystal composition and liquid crystal display panel
CN115746870A (en) Liquid crystal composition and liquid crystal display panel
CN117511566A (en) Liquid crystal composition and liquid crystal display panel
CN117487567A (en) Liquid crystal composition and liquid crystal display panel
CN116496795A (en) Liquid crystal composition and liquid crystal display panel
KR100544104B1 (en) Nematic liquid crystal composition and liquid crystal display device using the same
JP2525153B2 (en) Liquid crystal composition
CN115895679A (en) Liquid crystal composition and display panel
CN115746873A (en) Liquid crystal composition and liquid crystal display panel
CN117467449A (en) Liquid crystal composition and display panel
CN115975651A (en) Liquid crystal composition and display panel
JP2514607B2 (en) Liquid crystal composition
KR100544105B1 (en) Nematic liquid crystal composition and liquid crystal display device using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination